Results 91 to 100 of about 50,593 (147)

Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and Therapeutic Perspectives. [PDF]

Biomedicines
Xiong W, Miao D, Hou Z, Zhang X, Xiong Z.   +4 more
europepmc   +1 more source

PIN (Protein Inhibitor of Neuronal Nitric Oxide Synthase) Modulates Glucose Uptake Through NO-Dependent and Independent Mechanisms in Rat Muscle Cells. [PDF]

Antioxidants (Basel)
Leroy J, Mezghenna K, Tousch D, Canovas J, Laune D, Pugnière M, Azay-Milhau J, Lajoix AD.   +7 more
europepmc   +1 more source

The role of exosomal miRNA-125b derived from colon cancer-associated fibroblasts in skeletal muscle cachexia. [PDF]

PLoS One
Kim HS, Kim J, Lee B, Lee Y, Park SY, Oh BY, Cho KA, Chung SS, Noh GT.   +8 more
europepmc   +1 more source

Pro-Inflammatory Cytokines as Core Mediators of Colonic Epithelial Barrier Dysfunction: Roles of TNF-α, IFN-γ, IL-1β, and IL-6. [PDF]

Int J Mol Sci
V Thanga Velu DP, Fauzi MB, Jaafar F, Mokhtar NM, Mokhtar MH, A Hamid A.   +5 more
europepmc   +1 more source

Effect of mavacamten on sudden cardiac death risk scores in obstructive hypertrophic cardiomyopathy. [PDF]

ESC Heart Fail
Usai P, Cariou E, Donal E, Eyharts D, Cohen N, Lucas C, Al Wazzan A, Cherbi M, Itier R, Fournier P, Habib G, Lairez O.   +11 more
europepmc   +1 more source

The coiled-coil domain of myosin-11 as a potential biomarker to detect patients with atherosclerotic cardiovascular disease risk. [PDF]

J Physiol Sci
Takahashi L, Tomiyama H, Kobori H, Hidaka Y, Orihara S, Uchida K, Satomi K, Taguri M, Chikamori T, Yokoyama U.   +9 more
europepmc   +1 more source

Therapeutic Response to Myosin Inhibitor Therapy in Noonan Syndrome-Associated Obstructive Hypertrophic Cardiomyopathy. [PDF]

JACC Case Rep
Feidakis A, Nies R, Kural M, Pennig L, Winnerling N, Erger F, Pfister R, Seuthe K.   +7 more
europepmc   +1 more source

Restoring dendritic cell interstitial motility via PDE5 inhibition for sustained antitumor immunity. [PDF]

J Natl Cancer Cent
Zang R, Zhang C, Ding G, Zhang J.
europepmc   +1 more source

Efficacy and safety of mavacamten in non-obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis of randomized trials. [PDF]

Int J Cardiol Heart Vasc
Abdullah M, Thalib HI, Tahir MB, Khalid N, Mushtaq A, Afzal MA, Moore MD, Sharma N, Muddassir S, Ayers MP, Albaghdadi M, Aronow WS.   +11 more
europepmc   +1 more source

Case Report: Mavacamten in mid-ventricular and apical hypertrophic cardiomyopathy-a case of targeted therapy beyond left ventricular outflow tract obstruction. [PDF]

Front Med (Lausanne)
Yang L, Dai H, Rong Y.
europepmc   +1 more source